Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
rosiglitazone
AVA105640
NCT00428090
Alzheimer's Disease
Phase 3
 
A follow-up study AVA102677 was conducted.
May 2013

Powered by ideaPoint, Inc.